⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
AI in Longevity Medicine
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-11 — Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.: Conceptual review [expert-opinion] proposes ‘Longevitomics’/‘Longevitome’ as a framework integrating multi-omics, environmental exposures, digital phenotyping, and AI digital twins to model healthy-longevity trajectories; this is a research-framing signal, not evidence of consumer uptake, and the supplied finding provides no new predictive-validation, clinical-benefit, or data-safety results. [expert-opinion] (novelty: 3)
- 2026-11-05 — Insilico Open-Sources 24/7 Personal Longevity Superintelligence to Turn Quantified-Self Data into Predictive Health States and Aging Research: News report, no new validation data [anecdotal-biohack]: Insilico Medicine reportedly open-sourced a platform marketed as a ‘24/7 Personal Longevity Superintelligence’ for converting continuous quantified-self data into predictive health and aging states—an access-and-promotion trend signal, not demonstrated adoption; the supplied finding establishes neither predictive accuracy nor clinical or longevity benefit and leaves sensitive-data handling and safeguards against misleading health interpretations unresolved. [anecdotal-biohack] (novelty: 3)
- 2026-10-23 — A Methodological Framework for a Large Language Model Virtual Companion for Older Adults at Risk of Social Isolation.: An 8-week RCT (n=160) of an LLM-driven virtual companion for older adults at risk of social isolation reports feasibility, usability, and favorable changes in loneliness and depressive symptoms [human-rct]; the supplied summary omits effect sizes, comparator details, and adverse-event reporting, establishes no longevity benefit, and supplies no media or community uptake evidence. [human-rct] (novelty: 3)
- 2026-10-31 — Comparison of the effects of artificial intelligence, virtual reality, and traditional balance training programs on balance and gait in older adults.: An 8-week randomized controlled trial in older adults reported significantly greater gait-speed gains with both a ChatGPT-4o-generated exercise program and VR exergaming than with traditional balance training [human-rct]; this supports a specific short-term functional outcome, not general AI coaching efficacy or longevity benefits, and the supplied summary provides no sample size, effect magnitude, adverse-event details, or evidence of consumer uptake. [human-rct] (novelty: 3)
- 2026-11-06 — A gait foundation model for prediction of multisystem health phenotypes from 3D skeletal motion.: Human observational model-development study [human-observational] reports that a foundation model using single-depth-camera 3D skeletal gait data predicts age (r=0.69), frailty, and health phenotypes across 18 body systems; these predictive associations do not establish a validated measure of biological aging or improved clinical outcomes, and this finding supplies no evidence of consumer adoption or media spread. [human-observational] (novelty: 4)
- 2026-11-09 — Machine Learning-Based Biomechanical and Clinical Assessment of the Five Times Chair Rise Test in Older Adults: Sensor-Based Functional Aging Study.: A 24-month observational study in older adults found that machine-learning clustering of sensor-derived ground reaction forces during the Five Times Chair Rise Test distinguished functional trajectories not captured by stopwatch timing alone [human-observational], extending AI-based functional assessment without establishing that its use improves clinical outcomes or slows aging. [human-observational] (novelty: 3)
- 2026-10-07 — Large Language Model-Based Identification of Subjective Cognitive Decline in Electronic Health Records Among Older Adults With Normal Cognitive Testing: Retrospective Cohort Study.: 2026 — Retrospective cohort applied a validated 2-stage LLM pipeline to EHRs of older adults with normal cognitive testing and identified documented subjective-cognitive-decline-consistent concerns in 13.8%, with documentation uncommon and selectively associated with clinical/sociodemographic factors — extends AI’s remit into EHR phenotyping of subjective cognitive decline, a measurement-equity and phenotype-validity contribution rather than a biology claim. [human-observational] (novelty: 3)
- 2026-10-01 — Digital STEADI Efficacy: 2026 — Early-stage trial of Digital STEADI applies gen-AI conversational agents with human clinician oversight to deliver the CDC STEADI fall-prevention framework at home to community-dwelling older adults including those with MCI; evaluates access, adherence, and fall-risk reduction — extends AI’s remit from biomarkers/chatbots into guideline-based geriatric intervention delivery, no outcome readout yet. [human-rct] (novelty: 3)
- 2026-10-05 — AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.: PRISMA-ScR scoping review of 161 studies organizes AI-enabled intrinsic-capacity assessment into a 3D devices–digital-biomarkers–AI-techniques framework, finding cognition and locomotion well-covered but vitality, hearing, and multidomain IC underdeveloped and lacking external validation. [expert-opinion] (novelty: 3)
- 2026-07-06 — From organ age gaps to precision geromedicine: Multi-omic and imaging frameworks for heterogeneous biological aging.: cross-connection with precision-geromedicine-protocols: Organ-age-gap framework links AI-driven multi-omic/imaging clocks to the precision-geromedicine stratification layer, with the review flagging tissue-origin inference as the key open validation gap. (novelty: 3)
- 2026-07-07 — AI-driven advances in vascular aging research: From mechanisms to precision medicine.: 2026 — Field-level review synthesizes AI applications to vascular aging — multi-omics biomarker discovery, CT plaque/calcium quantification, and retinal- and PPG-derived vascular aging clocks — as a precision-medicine pipeline for early detection and individualized risk; synthesis only, no new primary data, extends the AI-biomarker axis into cardiovascular aging. [expert-opinion] (novelty: 3)
- 2026-10-01 — AI-Driven Multimodal Risk Assessment Combining CT Imaging Biomarkers and Frailty Scores for Enhanced Mortality Prediction in Surgery Patients.: 2026 — Retrospective cohort (n=7,672 surgical patients) found that adding AI-derived CT body-composition and aortic-calcification biomarkers to an ICD-based Risk Analysis Index frailty score improved one-year postoperative mortality prediction (+0.04 AUROC) with better calibration and net benefit than frailty scoring alone; single-center observational, no external validation yet — extends the AI-biomarker axis into multimodal perioperative risk stratification. [human-observational] (novelty: 3)
- 2026-08-20 — Effects of NLP Chatbots on Loneliness, Depression, and Quality of Life Among Older Adults: A Systematic Review.: 2026 — Systematic review of 11 trials of NLP-based chatbots in older adults reports reductions in loneliness and depression with high acceptability but no significant effect on overall quality of life; extends AI’s remit from biomarkers/discovery into conversational psychosocial interventions, with primary efficacy coverage spun out to a dedicated chatbot page. [human-rct] (novelty: 3)
- 2026-05-30 — Development of Machine Learning-Driven Dual-Task Gait Test Model for Cognitive Impairment Screening.: 2026 — Cross-sectional ML study in community-dwelling adults ≥60 reports an AI-aided dual-task gait test screening for dementia (AUC 0.883) and cognitive impairment (AUC 0.895), with gait speed and stride variability as top features; observational diagnostic-accuracy signal, no prospective or external-cohort validation yet — extends the AI-screening axis into gait-based cognitive triage. [human-observational] (novelty: 3)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: Review proposes network pharmacology, AI target screening, and proteomic aging clocks as the translational toolkit for decoding multi-component TCM formulas — extends AI’s remit into traditional-medicine deconvolution, no primary validation. [expert-opinion] (novelty: 3)
- 2026-09-27 — Greek singer dies during anti-aging treatment as doctors allegedly turn to ChatGPT for CPR: Ynetnews report alleges clinic staff turned to ChatGPT for CPR guidance during a fatal anti-aging treatment — off-label emergency use of a general LLM at the point of care, unrelated to the discovery/biomarker AI narrative but a first mainstream data point on frontline LLM misuse in a longevity setting. [anecdotal-biohack] (novelty: 3)
- 2026-09-17 — Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study: Insilico Medicine press coverage announces opening its AI longevity discovery toolkit to researchers worldwide, tied to a Cell cover study; secondary news coverage of tooling accessibility, no independent validation of the toolkit’s outputs. [expert-opinion] (novelty: 3)
- 2026-09-15 — Insilico Launches AI-driven Longevity Vaccines Research for Aging-related Diseases and Human Longevity: Company press release: Insilico Medicine announces launch of an AI-driven longevity-vaccines R&D program targeting aging-related diseases; corporate announcement only, no target antigens, preclinical data, or trial design disclosed — extends the AI-designed-geroprotector narrative into prophylactic vaccines. [expert-opinion] (novelty: 3)
- 2026-09-01 — An open benchmark and language models for AI in aging biology.: 2026 — LongevityBench introduces an open multi-domain benchmark for aging-biology tasks; no single frontier LLM dominated, omics-based age prediction was hardest, and compact fine-tuned Longevity-LLMs (0.6B–9B) matched or beat much larger general models, released with an agentic research interface — methodology/tooling contribution, not a clinical outcome. [expert-opinion] (novelty: 4)
- 2026-08-25 — Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy: 2026 — Feasibility study protocol will pilot FaceAge, a facial-image deep-learning biological-age estimator, as a secondary vulnerability-screening tool alongside a Practical Geriatric Assessment in older NSCLC patients receiving SBRT; extends the AI-biomarker axis into oncology-geriatrics triage, design only, no accuracy or outcome readout yet. [expert-opinion] (novelty: 3)
- 2026-09-09 — Longevity Metrics AI/ML Development Study: Longevity Metrics describes an AI/ML pipeline that video-scores functional screening tests, imputes missing battery results, and predicts clinical judgment and life expectancy — linked to the 100-Year Human Aging Study cohort as substrate; measurement-methodology development, no outcome readout yet. [human-observational] (novelty: 3)
- 2026-09-09 — Apple’s New Longevity Tools Will Tell You How Well You’re Actually Aging: cross-connection with consumer-longevity-wearables: Apple’s consumer aging metrics will likely be derived via AI/ML on wearable signals, tying mainstream device tooling to the AI-in-longevity claim stack. (novelty: 4)
- 2026-08-28 — Michael Snyder: We Need to Track Health, Not Disease: 2026 — Michael Snyder press appearance argues wearables + multi-omics streams (the substrate AI longevity tools depend on) should be used to model individual health trajectories proactively; expert-opinion signal reinforcing the wearables/digital-phenotyping axis, no new algorithm or outcome data. [expert-opinion] (novelty: 3)
- 2026-09-07 — Insilico’s IPF candidate rentosertib shows anti-aging promise: FirstWord Pharma industry-press item frames Insilico Medicine’s AI-discovered IPF candidate rentosertib as showing ‘anti-aging promise’; headline-only coverage with no new primary data, trial design, or endpoints disclosed — trend/media signal for AI-designed geroprotector pipelines, not verifiable outcome evidence. [expert-opinion] (novelty: 3)
- 2026-09-07 — Early Data Indicates an A.I.-Generated Drug Could Slow Aging: NYT headline reports ‘early data’ that an AI-generated drug could slow aging; mainstream-press signal only, no compound name, trial design, or primary readout disclosed — trend/media momentum, not verifiable evidence. [expert-opinion] (novelty: 3)
- 2026-09-07 — AI-designed drug candidate reverses biological age in clinical study: News-Medical headline reports an AI-designed drug candidate reversed biological age in a clinical study; item carries no compound name, trial design, endpoints, or primary data — trend/media signal only, not verifiable evidence. [expert-opinion] (novelty: 3)
- 2026-04-15 — Dietary geroprotective peptides: structural determinants, AI-driven discovery, and synthetic biology production for healthy ageing.: Review positions AI-driven peptide discovery (structure–activity prediction, generative design) plus synthetic-biology production as the pipeline for scaling dietary geroprotective peptides into functional foods — narrative extension of AI’s remit into nutraceutical design, no primary validation data. [expert-opinion] (novelty: 3)
- 2026-06-10 — Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact.: Field-level review synthesizes AI applications across the geroscience continuum (hallmark biology → biomarkers → geroprotector design → geriatric clinic), naming hierarchical experimental validation and digital-ageism/ethics as prerequisites; synthesis only, no new primary data. [expert-opinion] (novelty: 3)
- 2026-07-01 — AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.: Preclinical proof-of-concept: AI-optimized antisense oligonucleotide LM2556 targeting LMNA 3’UTR reduced progerin/farnesylated pre-lamin A and extended median lifespan by ~83% with cardiovascular rescue in progeroid mouse models — animal-model evidence for AI-assisted therapeutic design, no human readout. [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
Artificial intelligence-assisted discovery of natural product geroprotectors: target prediction, aging biomarker identification, and drug repurposing.
13-nov-2026
novelty 2
per-area 3
strengthens
Longevitomics as the Science of the Longevitome: Towards a Unified Systems Science of Healthy Longevity.
11-nov-2026
novelty 3
per-area 3
strengthens
Bioscope.ai Advances Personalized Longevity Medicine Through New Partnerships and Platform Growth
10-nov-2026
novelty 2
per-area 2
mentions
Machine Learning-Based Biomechanical and Clinical Assessment of the Five Times Chair Rise Test in Older Adults: Sensor-Based Functional Aging Study.
09-nov-2026
novelty 3
per-area 3
strengthens
A gait foundation model for prediction of multisystem health phenotypes from 3D skeletal motion.
06-nov-2026
novelty 4
per-area 4
strengthens
Insilico Open-Sources 24/7 Personal Longevity Superintelligence to Turn Quantified-Self Data into Predictive Health States and Aging Research
05-nov-2026
novelty 3
per-area 3
strengthens
Comparison of the effects of artificial intelligence, virtual reality, and traditional balance training programs on balance and gait in older adults.
31-oct-2026
novelty 3
per-area 3
strengthens
A Methodological Framework for a Large Language Model Virtual Companion for Older Adults at Risk of Social Isolation.
23-oct-2026
novelty 3
per-area 3
strengthens
Comparative evaluation of time-to-event analysis methods for mobility limitation in older adults: A multi-cohort benchmarking study.
18-oct-2026
novelty 2
per-area 2
strengthens
Fractional-order dynamical modelling of neurophysiological reaction-diffusion model of adiposity-induced cognitive decline using physics-informed neural networks.
15-oct-2026
novelty 2
per-area 2
strengthens
Navigating machine learning and classical statistics in sarcopenia screening for community-dwelling older women.
12-oct-2026
novelty 2
per-area 2
weakens
Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data.
11-oct-2026
novelty 2
per-area 2
strengthens
Large Language Model-Based Identification of Subjective Cognitive Decline in Electronic Health Records Among Older Adults With Normal Cognitive Testing: Retrospective Cohort Study.
07-oct-2026
novelty 3
per-area 3
strengthens
AI-Supported Physiotherapy After Hip Fracture in Frail Older Adults
05-oct-2026
novelty 2
per-area 2
introduces
AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.
05-oct-2026
novelty 3
per-area 3
strengthens
NHRI Intelligent Voice Interactive Platform for High-Quality Community Living Among Older Adults
02-oct-2026
novelty 2
per-area 2
mentions
Technology-Assisted Cognitive Support for Older Adults With Mild Cognitive Impairment: Study Protocol for the DHEAL-COM COGNITIVE Quasi-Experimental Pilot Study.
02-oct-2026
novelty 2
per-area 2
mentions
Mapping the evolution of dual-task paradigms in cognitive aging: A bibliometric analysis of research landscapes and translational applications.
02-oct-2026
novelty 2
per-area 2
mentions
Being sensed, scored, and "connected": a social-gerontological critique of artificial intelligence-driven loneliness detection for older adults in Taiwan.
01-oct-2026
novelty 2
per-area 2
weakens
Digital STEADI Efficacy
01-oct-2026
novelty 3
per-area 3
strengthens
AI-Driven Multimodal Risk Assessment Combining CT Imaging Biomarkers and Frailty Scores for Enhanced Mortality Prediction in Surgery Patients.
01-oct-2026
novelty 3
per-area 3
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
Greek singer dies during anti-aging treatment as doctors allegedly turn to ChatGPT for CPR
27-sep-2026
novelty 3
per-area 3
strengthens
Effectiveness of a Smartphone Chatbot to Improve Exercise Adherence in Older Adults
25-sep-2026
novelty 2
per-area 2
mentions
Rationale, Design, and Baseline Characteristics of the TARGET (Targeted Assessment and Recruitment of Geriatrics for Effective Fall Prevention Treatments) Cohort of Older Adults for Assessing Fall and Fracture Risk: Prospective Cohort Study.
25-sep-2026
novelty 3
per-area 2
mentions
Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
17-sep-2026
novelty 3
per-area 3
strengthens
Artificial Intelligence in Extended Reality and Digital Rehabilitation Technologies for Fall Prevention in Older Adults: A Rapid Review of the Evidence.
17-sep-2026
novelty 2
per-area 2
mentions
Insilico Launches AI-driven Longevity Vaccines Research for Aging-related Diseases and Human Longevity
15-sep-2026
novelty 3
per-area 3
strengthens
Your Personal Longevity Assistant: Evipedia Grok Bot
11-sep-2026
novelty 2
per-area 2
mentions
Digital Healthy Aging in China: Current Landscape and the Way Forward.
11-sep-2026
novelty 2
per-area 2
strengthens
Longevity Metrics AI/ML Development Study
09-sep-2026
novelty 3
per-area 3
strengthens
AI-designed drug could slow aging; chatbots abandon referral advice when patients push back; virtual reality helped anxious patients finish cardiac scans — Morning Medical Update
09-sep-2026
novelty 2
per-area 2
mentions
Automation of Screening Studies for Compounds that Slow Aging is Becoming More Ambitious
09-sep-2026
novelty 2
per-area 2
mentions
AI anti-aging drug shows early promise, plus fall allergy tips and coffee's effect on teeth
08-sep-2026
novelty 2
per-area 2
mentions
Insilico's IPF candidate rentosertib shows anti-aging promise
07-sep-2026
novelty 3
per-area 3
strengthens
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
07-sep-2026
novelty 3
per-area 3
strengthens
AI-designed drug candidate reverses biological age in clinical study
07-sep-2026
novelty 3
per-area 3
strengthens
An open benchmark and language models for AI in aging biology.
01-sep-2026
novelty 4
per-area 4
strengthens
Michael Snyder: We Need to Track Health, Not Disease
28-aug-2026
novelty 3
per-area 3
strengthens
Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
25-aug-2026
novelty 3
per-area 3
strengthens
Effects of NLP Chatbots on Loneliness, Depression, and Quality of Life Among Older Adults: A Systematic Review.
20-aug-2026
novelty 3
per-area 3
strengthens
Artificial Intelligence-Based Health Assessment From Face Photographs - Healthy Volunteer Study
17-aug-2026
novelty 2
per-area 2
mentions
CT-based prediction of hematoma expansion and adverse outcomes after intracerebral hemorrhage: evidence appraisal, artificial intelligence translation, and GeroScience perspectives.
15-aug-2026
novelty 2
per-area 2
mentions
Global trends in endothelial cell senescence research in cardiovascular diseases: A multi-tool bibliometric analysis (2001-2024).
01-aug-2026
novelty 2
per-area 1
mentions
Comment on "nutritional impact of leucine-enriched supplements: Evaluating protein type through artificial intelligence (AI)-Augmented muscle ultrasonography in hypercaloric, hyperproteic support".
31-jul-2026
novelty 1
per-area 2
mentions
Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence.
30-jul-2026
novelty 2
per-area 3
strengthens
cMIND AI Web Tool Usability Study (Hong Kong)
29-jul-2026
novelty 2
per-area 2
strengthens
The Effects of an AIoT-Based Exercise System on Frail Older Adults
13-jul-2026
novelty 2
per-area 2
introduces
AI-driven advances in vascular aging research: From mechanisms to precision medicine.
07-jul-2026
novelty 3
per-area 3
strengthens
Body composition's effect on the bone-vascular axis of osteoporosis discovered in AI-based CT analysis of COPD patients.
03-jul-2026
novelty 3
per-area 2
mentions